Hsu PI, Chen KY, Tai WC, Yang JC, et al. Hybrid, high-dose dual and bismuth quadruple therapies for first-line treatment of Helicobacter pylori infection in Taiwan: a multicenter, open-label, randomized trial. Am J Gastroenterol 2023 Mar 20. doi: 10.14309/ajg.0000000000002255.
PMID: 36940437